| Literature DB >> 28089683 |
Rémi Buisson1, Joshi Niraj2, Amélie Rodrigue2, Chu Kwen Ho1, Johannes Kreuzer1, Tzeh Keong Foo3, Emilie J-L Hardy1, Graham Dellaire4, Wilhelm Haas1, Bing Xia3, Jean-Yves Masson5, Lee Zou6.
Abstract
ATR is a key regulator of cell-cycle checkpoints and homologous recombination (HR). Paradoxically, ATR inhibits CDKs during checkpoint responses, but CDK activity is required for efficient HR. Here, we show that ATR promotes HR after CDK-driven DNA end resection. ATR stimulates the BRCA1-PALB2 interaction after DNA damage and promotes PALB2 localization to DNA damage sites. ATR enhances BRCA1-PALB2 binding at least in part by inhibiting CDKs. The optimal interaction of BRCA1 and PALB2 requires phosphorylation of PALB2 at S59, an ATR site, and hypo-phosphorylation of S64, a CDK site. The PALB2-S59A/S64E mutant is defective for localization to DNA damage sites and HR, whereas the PALB2-S59E/S64A mutant partially bypasses ATR for its localization. Thus, HR is a biphasic process requiring both high-CDK and low-CDK periods. As exemplified by the regulation of PALB2 by ATR, ATR promotes HR by orchestrating a "CDK-to-ATR switch" post-resection, directly coupling the checkpoint to HR.Entities:
Keywords: ATR; BRCA1; CDK; PALB2; checkpoint; homologous recombination
Mesh:
Substances:
Year: 2017 PMID: 28089683 PMCID: PMC5496772 DOI: 10.1016/j.molcel.2016.12.007
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970